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Effect of a clinical evidence technology on patient
skin disease outcomes in primary care: a clusterrandomized controlled trial
Marianne Burke, MA, AHIP; Benjamin Littenberg, MD
See end of article for authors’ affiliations.

Objective: Providers’ use of clinical evidence technologies (CETs) improves their diagnosis and treatment
decisions. Despite these benefits, few studies have evaluated the impact of CETs on patient outcomes. The
investigators evaluated the effect of one CET, VisualDx, on skin problem outcomes in primary care.
Methods: A cluster-randomized controlled pragmatic trial was conducted in outpatient clinics at an academic
medical center in the northeastern United States. Participants were primary care providers (PCPs) and their
adult patients seen for skin problems. The intervention was VisualDx, as used by PCPs. Outcomes were
patient-reported time from index clinic visit to problem resolution, and the number of follow-up visits to any
provider for the same problem. PCPs who were randomly assigned to the intervention agreed to use VisualDx
as their primary evidence source for skin problems. Control group PCPs agreed not to use VisualDx.
Investigators collected outcome data from patients by phone at thirty-day intervals. Cox proportional hazards
models assessed time to resolution. Wilcoxon-rank sum tests and logistic regression compared the need for
return appointments.
Results: Thirty-two PCPs and 433 patients participated. In proportional hazards modelling adjusted for
provider clusters, the time from index visit to skin problem resolution was similar in both groups (hazard
ratio=0.92; 95% confidence interval [CI]=0.70, 1.21; p=0.54). Patient follow-up appointments did not differ
significantly between groups (odds ratio=1.26; CI=0.94, 1.70; p=0.29).
Conclusion: This pragmatic trial tested the effectiveness of VisualDx on patient-reported skin disease
outcomes in a generalizable clinical setting. There was no difference in skin problem resolution or number of
follow-up visits when PCPs used VisualDx.

See end of article for supplemental content.

INTRODUCTION
Health care providers across a spectrum of primary
care and specialty domains regularly refer to clinical
evidence technologies (CETs) to answer clinical
questions [1]. As reported in provider survey and
chart review studies, use of CETs such as
PubMed/MEDLINE, journal articles, electronic
texts, topic summaries, and Internet search engines
has improved diagnosis and treatment decisions and
avoided adverse events [2–6]. Despite these provider
reports, few studies have evaluated the impact of
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CETs on patient-level outcomes. Patient-level
outcomes include mortality, relief of symptoms,
impact on activity, perceived benefit, and costs to
the patient, such as length of hospital stay and lost
work time [7]. The literature on patient outcomes of
CET use is mixed. Only one published study has
reported an improvement in patient outcomes.
Researchers reviewed insurance claims from
hospitals before and after subscribing to UpToDate
(a source for comprehensive medical topic
summaries). Results showed a modest reduction in
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morbidity and length of stay in hospitals after
subscribing [8].
Hospital libraries and informatics centers
acquire and make CETs available to the clinical
community on the assumption that these resources
have value for education, practice improvement,
and outcomes of care. CET licenses can be
expensive. Medical school libraries associated with
teaching hospitals in the United States or Canada
spent an average of US$2 million each in 2015 for
medical research journals and clinical information
resources [9]. While CETs, individually or in
combination, have been evaluated for education and
practice-level outcomes, they have not undergone
rigorous evaluations with randomized trials for
patient outcomes. A 2015 systematic review of
electronic health information, including CETs, found
no randomized trials with patient outcomes, such as
utilization or relief from symptoms [10].
The broad nature and diverse goals of many
CETs may discourage rigorous evaluation.
However, skin conditions are a relatively
circumscribed domain within the broad field of
primary care. The clinical goal in many cases can be
quantified as time-to-problem resolution. Likewise,
the need for additional medical care after the index
visit usually represents a suboptimal and expensive
outcome that might be reduced by improved
provider knowledge and decision support [11].
Skin problems account for 15% of primary care
office visits in the United States [12], and 10 common
dermatologic conditions (dermatitis, pyoderma,
tinea, benign neoplasms, candida, dermatosis, warts,
malignant neoplasm, sebaceous cyst, and acne)
account for 77% of skin-related diagnoses in family
practices. Likewise, many internal conditions
manifest themselves on the skin, including
malignancies, vascular conditions, anemia,
endocrine disorders, and pregnancy. Most skin
conditions first present, and are often diagnosed and
managed, in primary care. Eight percent of all
outpatient visits for skin problems result in referrals
to dermatologists or return visits to primary care
[13]. Limitations in the ability of primary care
providers (PCPs) to diagnose skin rashes and lesions
correctly have been noted in the literature [14, 15].
Some studies indicate that additional dermatology
knowledge, training, and diagnostic support could
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improve practice and patient outcomes. General
practitioners in the United Kingdom who used an
online source for skin cancer diagnosis information
increased their diagnostic accuracy and confidence,
but referrals were not reduced [16]. Referrals to
dermatology in a Veterans Affairs hospital that
lacked a specific diagnosis were reduced by an
intervention that trained PCPs [17].
VisualDx is a CET that presents images and text
on a comprehensive range of skin conditions and
symptoms that are local to the skin or manifestations
of internal conditions [18]. Users can search by
diagnosis or by patient characteristics and
examination findings to generate a differential
diagnosis list with images. Individuals, practices,
and institutions license VisualDx to support medical
education and patient care [19]. VisualDx has been
shown to improve diagnostic competency in non–
primary care settings. In one study, its use improved
the differential diagnosis of cellulitis by emergency
room physicians [20]. In a pilot study, diagnostic
accuracy of dermatology residents and medical
students increased after using VisualDx, as judged
by a consultant dermatologist [21].
Given the prevalence and broad range of skin
conditions seen in primary care, the need for PCPs’
improved knowledge and competency in skin
disease, the availability of a dermatology-focused
CET (i.e., VisualDx) that has been shown to affect
clinical competence, and the lack of randomized
clinical trials of any CET with patient-level
outcomes, the authors proposed a clinical trial to
evaluate use of VisualDx in primary care in the
domain of skin disease with patient-level outcomes.
Our objective was to evaluate the effect of
VisualDx on duration of symptoms and follow-up
care for skin problems in a pragmatic randomized
clinical trial in primary care. Recognizing that in
typical clinical care, the correct diagnosis and
therapy are often uncertain, that some problems
resolve regardless of whether the management was
technically correct, and that some resist even the
most insightful management, we were concerned in
this study with the net result of each episode of
care—the patient outcomes—rather than the
intermediate steps of management (i.e., diagnosis or
treatment decisions).
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METHODS
Study design, model, and setting
We designed a cluster-randomized controlled trial to
evaluate the outcomes of skin problems for patients
whose PCP referred to VisualDx or not (usual care).
In this design, PCPs were the subjects of
randomization. Patients were clustered in the arm of
the provider they saw for the skin problem. The
cluster design was appropriate because the
intervention was directed to physicians, while the
outcomes occur in individual patients [22]. With
randomization, environmental and provider or
subject characteristics (e.g., years in practice,
insurance status, chronicity of the presenting
complaint, comorbidities) were distributed at chance
levels across both arms of the experiment.
The model underlying the design of the
experiment asserted that the CET supported PCPs in
management (i.e., diagnosis, treatment, and referral
decisions) and impacts patient-level outcomes—
resolution of symptoms and return appointments—
when used in a real-world clinical setting.
Presumably, use of a valuable CET leads to more
correct diagnoses and wiser therapeutic or referral
choices. These, in turn, lead to better patient
outcomes (i.e., quicker resolution of the presenting
problem or reduced need for additional care). To test
this model, we performed a pragmatic [23] (i.e., not
heavily controlled) cluster-randomized controlled
trial of the impact of one CET on the outcomes of
skin problems presenting to primary care (Figure 1).

The study was conducted at clinics associated
with an academic regional medical center in the
northeast United States. VisualDx and other CETs
were available to medical center clinicians through
the hospital intranet, electronic health record, and
mobile devices. The institutional review board
approved the protocol in June 2015.
Provider subjects
Attending physicians, residents, advanced practice
nurses, and physician assistants in outpatient family
medicine and general internal medicine were invited
to participate by email or personal contact. Eligible
providers (1) were currently seeing patients at a
primary care site, (2) consented and agreed to
comply with the protocol procedures assigned, and
(3) permitted patients to be informed of the study
via a letter sent over their signature. Providers
answered a survey concerning resident or attending
status, year of clinical degree, sex, specialty, and
typical number of times per month that they used
CETs for patient care (supplemental Appendix A).
We randomly assigned PCPs to intervention or
control groups using a sequential numbered
envelope method, stratified by resident status [24].
We randomized residents independently because of
the possibility that they might respond differently to
the intervention than more experienced providers
would. PCPs were enrolled in the study when they
gave consent, completed the tutorial, provided their
signature for patient letters, and affirmed their
agreement to follow their assigned protocol.

Figure 1 Model of the cluster-randomized pragmatic design

PCP=primary care provider; CET=clinical evidence technology.
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Patient subjects
Adult patients seen for acute or chronic skin
problems, excluding lacerations or burns, were
eligible. Patients were excluded if they did not speak
English or were decisionally impaired. To identify
patients, we reviewed the appointment records of
participating providers for patients who were seen
for a skin problem. We identified patients with any
complaint in the broad range of skin diseases as
noted in the electronic health record. The reason for
visit, appointment note, and clinical summary fields
provided information about patient complaints,
such as “rash,” “redness,” “lump,” “itch,” “wart,”
“mole,” or “sore.” International Classification of
Diseases codes were also used to identify potential
cases. Per the institutionally approved protocol,
personal health information from the patient
record—such as reason for visit, phone number, and
address—could be used for identification and
recruitment but not to ascertain patient
characteristics or outcomes.
We sent each identified patient a letter signed by
their PCP describing the study and informing them
that the study team would call to invite their
participation. The letter also stated how to opt out of
any contact.
Intervention
The intervention was VisualDx, as used by PCPs
treating patients with skin problems. Providers
received email notification of their experimental
group status with a link to a self-paced slide tutorial
that was specific to their group (supplemental
Appendixes B and C). For the “Active” group, the
five-to-ten-minute tutorial included the direction to
use VisualDx when needed in treating a patient skin
problem and instructions on how to access and use
the CET. For the “Control” group, the tutorial
included the direction not to use VisualDx and a
general orientation to information sources that are
available through the medical library. A study team
member contacted participating providers by email,
phone, and letter at intervals during the study to
remind them of their assigned protocol and to
confirm their continued participation.
Measurements
The primary predictor (i.e., independent variable)
was the randomized group status of the provider:
Active (use of VisualDx) or Control (non-use).

Journal of the Medical Library Association

Patient subjects were assigned to the group of the
provider they saw. The primary outcome variables
reported by the patients were (1) time to resolution
of the skin problem from presentation at the primary
care office visit and (2) number of follow up visits
(to any provider) for the same problem.
About thirty days after the index visit, an
investigator phoned each eligible patient (except
those who had opted out) and, following verbal
consent, proceeded with interview questions. If the
patient reported their presenting skin problem
resolved (i.e., “all better”), their participation in the
study was concluded. Patients whose presenting
complaint had not resolved were reinterviewed at
sixty days and, if still unresolved, again at ninety
days. The thirty-sixty-ninety day phone call
schedule was specified in the protocol to balance the
requirements to reach many people while
preserving patient recall [25].
At the first interview, patients reported their
ages, sexes, and whether the PCP seen was their
usual provider (supplemental Appendix D). We
ascertained the status of the skin problem as “all
better,” “improved,” “unchanged,” or “worse” each
time that we interviewed the patient. If it was “all
better” at any interview, we asked them to recall the
number of days from the index visit date or the date
when they realized the problem was resolved. If
necessary, we asked questions to aid more exact
recall. This determined the “days to resolution”
outcome variable. The final problem status at the
last completed interview was determined for
analysis.
To determine the number of follow-up
appointments, at the first interview, we asked how
many appointments the patient had had for the
same problem since the index visit. If there was a
second or third phone interview, we asked how
many appointments they had had since the last call
and added that number to any previously reported
appointments, if any. The total number of
appointments reported constituted the variable.
Data collection
Trained research assistants using standardized
scripts conducted patient interviews by phone.
Study data were collected and managed using
Research Electronic Data Capture (REDCap) secure
tools, hosted by the researchers’ institution.
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Blinding

RESULTS

By necessity, providers knew their own intervention
or control group status. Investigators were blind to
providers’ and patients’ groups while conducting
patient interviews. Patients were blind to the group
assignment of their providers.

We enrolled 31 physicians and 1 nurse practitioner.
We identified 989 eligible patients with a visit to a
participating PCP related to a skin problem between
November 2015 and August 2016. Four hundred
thirty-three patients consented and provided data
(Figure 2).

Analysis
We used Cox proportional hazards models to assess
time to resolution and Wilcoxon-rank sum tests and
logistic regression to compare return appointments
between groups. Logistic and proportional hazards
models were adjusted for clustering. Data analyses
were performed using Stata 14 statistical software.
We sought an adequate sample size to detect a
moderate-to-large effect of the intervention, on the
order of 0.4 standard deviations. Given the broad
range of skin problems presenting in primary care,
we expected significant variability in the time to
resolution. Therefore, we chose a target of 8 days to
resolution with a standard deviation of 20 days. The
effect of clustering with PCP was not known, but we
used estimates from other primary care settings that
suggested an intra-cluster correlation of
approximately 0.025 [26]. Assuming α=0.05, β=0.80,
10 patients per provider, and a 2-sided t-test, we
estimated the study needed 26 PCPs and 260
patients.

The Active and Control groups were similar at
baseline, except for the median number of subjects
per PCP (6 in the Active group versus 15 in the
Control group; p=0.045) (Table 1). Seven PCPs (22%)
reported use of VisualDx prior to the study,
including 4 (27%) in the Control group who agreed
not to use it during the trial.
Problem resolution
Nearly half (48%) of all patients in the study
considered their skin problem resolved (i.e., “all
better”) by the final contact, including 46% in the
Active group and 49% in the Control group (p=0.48).
Active and Control patients were similar in terms of
whether they were “all better,” “improved,”
“unchanged,” or “worse” at their final interview
(p=0.88) (Table 2, Figure 3).

Figure 2 Flow of participants through stages of the randomized-cluster controlled trial
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Table 1 Characteristics of primary care providers and patients
All
Primary care providers

Active

n=32

n=17

n

(%)

Residents

13

(41%)

Sex (male)

17

Family medicine (vs. internal
medicine)

14

Year graduated
Study patients per provider

p*

Control
n=15

n

(%)

n

(%)

8

(47%)

5

(33%)

0.43

(53%)

10

(59%)

7

(47%)

0.49

(45%)

6

(35%)

8

(53%)

0.30

median

(range)

median

(range)

median

(range)

2010

(1976–2015)

2012

(1976–2015)

2002

(1977–2015)

0.44

(1–32)

15

(1-34)

0.045

n

(%)

13.5

(1–34)

6

n

(%)

n

(%)

Used any CET ≥ 10 times in
the prior month

27

(84%)

13

(77%)

14

(93%)

0.19

Used VisualDx in the prior
month

7

(22%)

3

(18%)

4

(27%)

0.54

Patients

n=433

n=158

n=275

median

(range)

median

(range)

median

(range)

58

(19–94)

58

(20–91)

58

(19–94)

n

(%)

n

(%)

n

(%)

Sex (male), 431 obs.

214

(49%)

77

(49%)

137

(50%)

0.54

Completed all protocol
interviews

360

(83%)

126

(80%)

234

(85%)

0.15

Age in years, 431 obs.

0.73

*p-value comparing Active and Control groups from χ2 tests for categorical variables (proportions) and Wilcoxon rank-sum tests for ordinal and
continuous variables.

Table 2 Problem resolution and return visit outcomes
All subjects

Active

Control

n=433

n=158

n=275

Patients
n

(%)

n

(%)

n

p*

(%)

Final skin status

0.88

Resolved

207

(48%)

72

(46%)

135

(49%)

Improved

104

(24%)

41

(26%)

63

(23%)

Unchanged

108

(25%)

40

(25%)

68

(25%)

14

(3%)

5

(3%)

9

(3%)

Worse
Return visits

(standard
deviation)

mean

(standard
deviation)

mean

(standard
deviation)

(1.07)

0.65

(1.10)

0.55

(1.05)

n

(%)

n

(%)

n

(%)

148

(34%)

mean

Return visits per patient
Any return visits (vs. none)

0.59

59

(37%)

89

(32%)

0.19
0.29

*p-value comparing Active and Control groups from χ2 tests for categorical variables (proportions) and Wilcoxon rank-sum test for number of visits.
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Time to resolution was similar between groups
throughout the observation period of up to 120 days
(p=0.56 by log-rank test) (Figure 3).
In univariable Cox proportional hazards
models, with standard errors adjusted for provider
clusters, the days from index visit to resolution were
similar between groups (hazard ratio [HR]=0.92;
95% confidence interval [CI]=0.70, 1.21; p=0.54).
Tests for potential confounding by patient age and
sex, PCP status (as resident and as patient’s regular
provider), PCP time since graduation, number of
patients per provider, and time of the year indicated
no potential confounding. Therefore, these variables
were not included in the analysis.
Return appointments
Active group patients had a mean of 0.65 return
appointments compared to 0.55 in the Control group
(p=0.19). The median was 0 return appointments in
both groups (Figure 4). Thirty-seven percent of
Active group patients had 1 or more follow-up
appointments for the index problem, versus 32% of
Control group patients (p=0.29).

When analyzed as a binary variable (any followup visits vs. none) in cluster-adjusted logistic
regression, the odds of a return visit were higher in
the Active group than in the Control group (odds
ratio [OR]=1.25; 95% CI=0.93, 1.67; p=0.15), but this
was not statistically significant. Tests for potential
confounding by patient characteristics (age and sex),
PCP characteristics (as resident, as patient’s regular
provider, and time since graduation), or time of the
year indicated no confounding. Therefore, these
variables were not included in the model. However,
the number of patients per provider was associated
with the use of any follow-up visits (p=0.066) and
group assignment (p=0.065), raising the possibility
of confounding and warranting its inclusion in the
final logistic regression model. The odds of any
follow-up visits remained higher in the Active group
than in the Control group, when adjusting for
clustering and the number of patients per provider
(OR=1.14; 95% CI=0.84, 1.56; p=0.39), but this was
not statistically significant. The intra-cluster
correlation coefficient for both outcome measures
was <0.00001 with an upper 95% confidence limit of
0.039.

Figure 3 Proportion of patients whose skin problems remained unresolved over time
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Figure 4 Proportion of patients whose skin problems remained unresolved over time

DISCUSSION
Patients with skin problems whose PCPs used
VisualDx experienced similar rates of problem
resolution and similar time to resolution as patients
whose providers did not use this CET. There was no
difference in the number of follow-up visits to any
health care provider for the index skin problem.
The goal of this study was to assess the
effectiveness of a CET as used in a generalizable
clinical setting rather than to determine its
mechanism of action or efficacy under ideal
conditions. Therefore, we designed a “pragmatic
trial” in a clinical environment in which day-to-day
factors were not highly controlled. Pragmatic trials
seek to answer the question, “Does this intervention
work under usual conditions?” [23]. Intervention
PCPs had flexibility in how they followed their
assigned protocols to reference VisualDx when
uncertainty about patient care arose. They could
have searched in VisualDx by diagnosis terms, as
opposed to using the differential diagnosis support
tool. They could also have decided that assistance
was not needed with some patients and opt not to
employ the CET and could seek advice from
additional sources after consulting VisualDx.
We obtained data for the primary outcomes
from patient reports because we sought to
Journal of the Medical Library Association

understand the outcomes of care as experienced by
the patients. Patient-reported outcome measures
complement other health care indicators such as
provider-reported outcomes, chart review, and
insurance data. They are appropriate measures in
research when the intervention is incorporated into
treatment [27, 28] and are frequently used in clinical
trials of medical products, drugs, and health-related
quality-of-life studies [29].
We did not evaluate whether the diagnosis or
treatment that the PCP decided upon was correct by
an objective standard, such as expert dermatologist
review. Likewise, we did not distinguish
appropriate follow-up appointments or referrals
from unnecessary or avoidable ones, recording only
that a follow-up occurred.
Physician-reported benefits of referring to
CETs—such as correct diagnosis, treatment, and
avoidance of adverse events—have been previously
noted. In a multi-institutional survey of physicians
(n=4,906) and residents (n=1,290) in 118 hospitals,
Marshall et al. found that 36% of physicians and 42%
of residents changed a diagnosis after referring to a
clinical evidence source in a recalled, recent incident.
Physicians (29%) and residents (32%) also reported
avoiding unnecessary procedures or tests because of
the information that they used in the incident [5].

107 (2) April 2019
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Likewise, use of VisualDx may improve
diagnostic skills. A team including the developer of
VisualDx reported that among 28 cases initially
misdiagnosed as cellulitis in the emergency room,
VisualDx included the correct diagnosis in its
differential diagnosis list more often than the
admitting medical residents (64% vs. 14%; p=0.003).
In a pilot study by Chou, clinical diagnoses of 13
patients were made by 13 dermatology residents
and 51 medical students before and after using
VisualDx. Diagnostic accuracy increased from 63%
to 81% (p<0.01) as judged by a consultant
dermatologist [21]. Despite these positive
intermediate effects, the published literature,
including the study reported here, provides no
evidence of better patient outcomes.
Why did use of VisualDx—a technologically
sophisticated, well-designed, state-of-the-art CET—
fail to influence the tested outcomes for skin
disease? Some potential reasons for the negative
results in this trial, such as bias due to uneven
distribution of patient or provider characteristics,
were minimized by the randomized design of the
study. Another reason we found no difference
between groups could be that the VisualDx users
had insufficient knowledge of the resource to use it
effectively. However, Active group PCPs were made
aware of the resource, what it was meant to do, and
how to access it. They received more training on its
features, via an online tutorial, than is usually
available in clinical practice. Although the VisualDx
interface appears intuitive and easy to use compared
to other CETs, it is possible that PCPs had difficulty
finding the information that they needed. The
specific content and interactive diagnosis tool of
VisualDx, written largely by specialists, could be too
complex or time consuming in the primary care
setting. This may have contributed to busy clinicians
bypassing VisualDx at times, resulting in
suboptimal management.

will resolve (or not) at their own pace regardless of
the diagnosis and therapy offered. Nonetheless,
return appointments and referrals to dermatology
could conceivably be reduced with optimal primary
care management.
This study tested the effectiveness of VisualDx
for problem resolution and return visit frequency,
not for other outcomes such as improved diagnosis
or satisfaction with care. This was not a
comprehensive multi-attribute assessment of the
CET. Likewise, ease of use and usefulness were also
beyond the scope of this evaluation.
As VisualDx is costly, this study may help
health care organizations determine whether that
cost is appropriate for their local institutional goals
and settings.
Strengths and limitations
The randomized-cluster parallel design reduced the
likelihood of bias due to differences in provider and
patient subjects. Secular events occurring outside the
study, such as seasonal changes in skin-related
appointments, affected providers and patients in the
intervention and control groups equally because of
the randomized, parallel design.
The study took place in one large academic
medical center, possibly reducing generalizability to
other settings. However, the patients of the study
institution are similar to populations in rural regions
of the United States in terms of age, race, poverty
rates, and other factors.

Finally, it is possible that many skin problems
presenting in primary care are inherently resistant to
improvement no matter how well managed. They

Although this was the largest randomized study
of a CET with patient outcomes to date, the power to
detect a potential effect was limited. Given the
sample size of 433 patients, a control resolution rate
of 49% within 90 days, and assumption of α=0.05,
the study had 80% power to detect a resolution rate
of at least 63% in the Active group, using χ2 analysis.
The observed rate was 46% and, therefore, not
significantly different from Control. In the Cox
model, the observed HR of 0.92 (favoring Control)
was well under the minimum detectable HR of 1.24.
Likewise, the study had 80% power to detect a
difference of 0.30 return visits per patient. The
observed rate was 0.10 higher in the Active group.
Given that all analyses showed a trend toward
worse outcomes (i.e., longer time to resolution and
more return visits in the Active group), it is highly
unlikely that a larger study would have
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Even if the content acquired by the PCPs was
correct from a biomedical point-of-view, the PCPs
were not obligated to follow it. Indeed, local
availability of certain procedures, prescriptions, and
specialty referrals may make it unreasonable or
impractical to follow the advice of the CET,
potentially leading to the “no difference” result.
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demonstrated a statistically significant beneficial
effect.
The study relied on provider adherence to the
protocol based on their agreement to do so (which
was confirmed periodically). We did not have
independent confirmation of their adherence. There
might also have been contamination between
provider subjects since there were both Active and
Control providers in some clinics. While Active
group PCPs used VisualDx as their primary
resource for skin-related uncertainty and Control
group PCPs did not, both groups could use other
CETs and resources that were available in the
information-rich environment of the academic
medical center. This access could have masked a
positive effect of using VisualDx.
We had limited ability to independently
measure participant usage of VisualDx prior to the
study. However, at baseline, 22% of PCPs reported
use of VisualDx in the prior month with no
significant difference between groups. We did not
measure VisualDx use during the study.
Nevertheless, we did encourage provider adherence
to the protocol. When contacted, all providers
confirmed that they were staying within their
assigned protocol of using or not using VisualDx as
a reference.
The study relied upon the memory of patients,
which could have been faulty. However, the first
patient interviews followed the index visit by
approximately thirty days, which is a relatively
short time span [25]. Only one patient who
consented could not remember the skin problem
visit at all.
This study included patients with acute and
chronic conditions reflecting the usual variety of
skin conditions that are seen in primary care. It is
possible that a study of only acute skin conditions or
a study in an inpatient setting would have had a
different outcome.
Implications
While VisualDx did not make a difference in the
patient outcomes studied, it may have value for
other goals such as medical knowledge, decision
confirmation, and diagnostic confidence. The
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pragmatic study design with patient-level outcomes
proved to be feasible and could be extended to
evaluate other clinical evidence source technologies
that are relevant to health care.
CONCLUSION
The study showed no difference in resolution of
symptoms and return visits in patients of doctors
who referenced VisualDx. Although VisualDx and
other CETs can support institutional missions of
medical knowledge and practice improvement,
VisualDx does not appear to improve patient
outcomes for skin problems managed in primary
care.
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